α-1-antitrypsin variants and the proteinase/antiproteinase imbalance in chronic obstructive pulmonary disease

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 308, Issue 2, 2015, Pages L179-L190

  Sinden, Nicola J ^a   Baker, Michael J ^b   Smith, David J ^a   Kreft, Jan Ulrich ^a   Dafforn, Timothy R ^a   Stockley, Robert A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease; Enzyme kinetics; Reaction diffusion model; Serine proteinase; 1 antitrypsin

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; LEUKOCYTE ELASTASE; MYELOBLASTIN; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; ELASTIN;

ARTICLE; BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIFFUSION COEFFICIENT; EMPHYSEMA; ENZYME KINETICS; GENOTYPE; HUMAN; LUNG INTERSTITIUM; MEASUREMENT; PATHOPHYSIOLOGY; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; BLOOD; ENZYMOLOGY; GENETICS; LUNG; METABOLISM; NEUTROPHIL;

ALPHA 1-ANTITRYPSIN; ALPHA-MACROGLOBULINS; ELASTIN; HUMANS; LEUKOCYTE ELASTASE; LUNG; MYELOBLASTIN; NEUTROPHILS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84921262901     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00179.2014     Document Type: Article

References (60)

1. Bank U, Ansorge S. More than destructive: Neutrophil-derived serine proteases in cytokine bioactivity control. J Leukoc Biol 69: 197-206, 2001.
2. Baur X, Bencze K. Study of familial α-1-proteinase inhibitor deficiency including a rare proteinase inhibitor phenotype (IZ). I α-1-phenotyping and clinical investigations. Respiration 51: 188-195, 1987.
3. Beatty K, Bieth J, Travis J. Kinetics of association of serine proteinases with native and oxidized α-1-proteinase inhibitor and α-1-antichymotryp-sin. J Biol Chem 255: 3931-3934, 1980.
4. Bergenfeldt M, Axelsson L, Ohlsson K. Release of neutrophil proteinase 4(3) and leukocyte elastase during phagocytosis and their interaction with proteinase inhibitors. Scand J Clin Lab Invest 52: 823-829, 1992.
5. Brantly ML, Wittes JT, Vogelmeier CF, Hubbard RC, Fells GA, Crystal RG. Use of a highly purified a 1-antitrypsin standard to establish ranges for the common normal and deficient a 1-antitrypsin phenotypes. Chest 100: 703-708, 1991.
6. Bristow CL, Di Meo F, Arnold RR. Specific activity of a1proteinase inhibitor and a2macroglobulin in human serum: Application to insulin-dependent diabetes mellitus. Clin Immunol Immunopathol 89: 247-259, 1998.
7. Campbell EJ, Campbell MA, Boukedes SS, Owen CA. Quantum proteolysis by neutrophils: Implications for pulmonary emphysema in a 1-antitrypsin deficiency. J Clin Invest 104: 337-344, 1999.
8. Campbell EJ, Campbell MA, Owen CA. Bioactive proteinase 3 on the cell surface of human neutrophils: quantification, catalytic activity, and susceptibility to inhibition. J Immunol 165: 3366-3374, 2000.
9. Cook L, Burdon JG, Brenton S, Knight KR, Janus ED. Kinetic characterisation of α-1-antitrypsin F as an inhibitor of human neutrophil elastase. Pathology 28: 242-247, 1996.
10. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ 309: 901-911, 1994.
11. Elliott PR, Bilton D, Lomas DA. Lung polymers in Z a1-antitrypsin deficiency-related emphysema. Am J Respir Cell Mol Biol 18: 670-674, 1998.
12. Eriksson S. Pulmonary emphysema and a1-antitrypsin deficiency. Acta Med Scand 175: 197-205, 1964.
13. Galdston M, Levytska V, Liener IE, Twumasi DY. Degradation of tropoelastin and elastin substrates by human neutrophil elastase, free and bound to a2-macroglobulin in serum of the M and Z (Pi) phenotypes for a1-antitrypsin. Am Rev Respir Dis 119: 435-441, 1979.
14. Kao RC, Wehner NG, Skubitz KM, Gray BH, Hoidal JR. Proteinase 3: A distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters. J Clin Invest 82: 1963-1973, 1988.
15. Kelly CP, Tyrrell DN, McDonald GS, Whitehouse DB, Prichard JS. Heterozygous FZ a 1 antitrypsin deficiency associated with severe emphysema and hepatic disease: Case report and family study. Thorax 44: 758-759, 1989.
16. Koj A, Regoeczi E, Toews CJ, Leveille R, Gauldie J. Synthesis of antithrombin III and α-1-antitrypsin by the perfused rat liver. Biochim BiophysActa 539: 496-504, 1978.
17. Korkmaz B, Attucci S, Jourdan ML, Juliano L, Gauthier F. Inhibition of neutrophil elastase by a1-protease inhibitor at the surface of human polymorphonuclear neutrophils. J Immunol 175: 3329-3338, 2005.
18. Korkmaz B, Attucci S, Juliano MA, Kalupov T, Jourdan ML, Juliano L, Gauthier F. Measuring elastase, proteinase 3 and cathepsin G activities at the surface of human neutrophils with fluorescence resonance energy transfer substrates. Nat Protoc 3: 991-1000, 2008.
19. Korkmaz B, Jaillet J, Jourdan ML, Gauthier A, Gauthier F, Attucci S. Catalytic activity and inhibition of Wegener antigen proteinase 3 on the cell surface of human polymorphonuclear neutrophils. J Biol Chem 284: 19896-19902, 2009.
20. Korkmaz B, Poutrain P, Hazouard E, de Monte M, Attucci S, Gau-thier FL. Competition between elastase and related proteases from human neutrophil for binding to a1-protease inhibitor. Am J Respir Cell Mol Biol 32: 553-559, 2005.
21. Kueppers F, Abrams WR, Weinbaum G, Rosenbloom J. Resistance of tropoelastin and elastin peptides to degradation by a 2-macroglobulin-protease complexes. Arch Biochem Biophys 211: 143-150, 1981.
22. Liou TG, Campbell EJ. Nonisotropic enzyme-inhibitor interactions: A novel nonoxidative mechanism for quantum proteolysis by human neu-trophils. Biochemistry 34: 16171-16177, 1995.
23. Liou TG, Campbell EJ. Quantum proteolysis resulting from release of single granules by human neutrophils: A novel, nonoxidative mechanism of extracellular proteolytic activity. J Immunol 157: 2624-2631, 1996.
24. Lomas DA, Evans DL, Finch JT, Carrell RW. The mechanism of Z a 1-antitrypsin accumulation in the liver. Nature 357: 605-607, 1992.
25. Lomas DA, Mahadeva R. a1-Antitrypsin polymerization and the serpi-nopathies: Pathobiology and prospects for therapy. J Clin Invest 110: 1585-1590, 2002.
26. Lucey EC, Stone PJ, Breuer R, Christensen TG, Calore JD, Catanese A, Franzblau C, Snider GL. Effect of combined human neutrophil cathepsin G and elastase on induction of secretory cell metaplasia and emphysema in hamsters, with in vitro observations on elastolysis by these enzymes. Am Rev Respir Dis 132: 362-366, 1985.
27. Mahadeva R, Chang WS, Dafforn TR, Oakley DJ, Foreman RC, Calvin J, Wight DG, Lomas DA. Heteropolymerization of S, I, and Z a1-antitrypsin and liver cirrhosis. J Clin Invest 103: 999-1006, 1999.
28. Mast AE, Enghild JJ, Pizzo SV, Salvesen G. Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: Comparison of a 1-protei-nase inhibitor, a 1-antichymotrypsin, antithrombin III, a 2-antiplasmin, angiotensinogen, and ovalbumin. Biochemistry 30: 1723-1730, 1991.
29. Medical Research Council Definition and classification of chronic bronchitis for clinical and epidemiological purposes. A report to the Medical Research Council by their Committee on the Aetiology of Chronic Bronchitis. Lancet 1: 775-779, 1965.
30. Meyer JF, Bieth J, Metais P. On the inhibition of elastase by serum. Some distinguishing properties of a1-antitrypsin and a2-macroglobulin. Clin Chim Acta 62: 43-53, 1975.
31. Moore AR, Appelboam A, Kawabata K, Da Silva JA, D'Cruz D, Gowland G, Willoughby DA. Destruction of articular cartilage by a 2 macroglobulin elastase complexes: role in rheumatoid arthritis. Ann Rheum Dis 58: 109-113, 1999.
32. Morton KW, Mayers DF. Numerical Solution of Partial Differential Equations, second ed. Cambridge University: Cambridge, UK, 2005.
33. Musumeci V, Vincenti A, Bizzi B. A method for the differential determination of plasma antithrombins. J Clin Pathol 29: 63-68, 1976.
34. Ogushi F, Fells GA, Hubbard RC, Straus SD, Crystal RG. Z-type a 1-antitrypsin is less competent than M1-type a 1-antitrypsin as an inhibitor of neutrophil elastase. J Clin Invest 80: 1366-1374, 1987.
35. Ogushi F, Hubbard RC, Fells GA, Casolaro MA, Curiel DT, Brantly ML, Crystal RG. Evaluation of the S-type of α-1-antitrypsin as an in vivo and in vitro inhibitor of neutrophil elastase. Am Rev Respir Dis 137: 364-370, 1988.
36. Ohlsson K. Comparison of affinity of trypsin for two macroglobulin fractions and for 1 antitrypsin in dog serum. Clin Chim Acta 32: 215-220, 1971.
37. Ohlsson K, Olsson I. Neutral proteases of human granulocytes. III. Interaction between human granulocyte elastase and plasma protease inhibitors. Scand J Clin Lab Invest 34: 349-355, 1974.
38. Oldham PD. Measurement of the prevalence of emphysema. Problems of definition and sampling. Proc R Soc Med 69: 127-128, 1976.
39. Owen CA, Campbell MA, Sannes PL, Boukedes SS, Campbell EJ. Cell surface-bound elastase and cathepsin G on human neutrophils: A novel, nonoxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases. J Cell Biol 131: 775-789, 1995.
40. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 364: 613-620, 2004.
41. Rao NV, Wehner NG, Marshall BC, Gray WR, Gray BH, Hoidal JR. Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties. J Biol Chem 266: 9540-9548, 1991.
42. Ross R, Bornstein P. Elastic fibers in the body. Sci Am 224: 44-52, 1971.
43. Sinden NJ, Koura F, Stockley RA. The significance of the F variant of α-1-antitrypsin and unique case report of a PiFF homozygote. BMC Pulm Med 14: 132, 2014.
44. Sinden NJ, Stockley RA. Proteinase 3 activity in sputum from subjects with α-1-antitrypsin deficiency and COPD. Eur Respir J 41: 1042-1050, 2013.
45. Stockley RA. Neutrophils and the pathogenesis of COPD. Chest 121: 151S-155S, 2002.
46. Stockley RA, Mistry M, Bradwell AR, Burnett D. A study of plasma proteins in the sol phase of sputum from patients with chronic bronchitis. Thorax 34: 777-782, 1979.
47. Stockley RA, Parr DG, Piitulainen E, Stolk J, Stoel BC, Dirksen A. Therapeutic efficacy of α-1 antitrypsin augmentation therapy on the loss of lung tissue: An integrated analysis of 2 randomised clinical trials using computed tomography densitometry. Respir Res 11: 136, 2010.
48. Stone PJ, Calore JD, Snider GL, Franzblau C. Role of a-macroglob-ulin-elastase complexes in the pathogenesis of elastase-induced emphysema in hamsters. J Clin Invest 69: 920-931, 1982.
49. Tashkin DP, Clark VA, Coulson AH, Simmons M, Bourque LB, Reems C, Detels R, Sayre JW, Rokaw SN. The UCLA population studies of chronic obstructive respiratory disease. VIII. Effects of smoking cessation on lung function: A prospective study of a free-living population. Am Rev Respir Dis 130: 707-715, 1984.
50. Travis J. Structure, function, and control of neutrophil proteinases. Am J Med 84: 37-42, 1988.
51. Turino GM, Barker AF, Brantly ML, Cohen AB, Connelly RP, Crystal RG, Eden E, Schluchter MD, Stoller JK. Clinical features of individuals with PI*SZ phenotype of a 1-antitrypsin deficiency. a 1-An-titrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med 154: 1718-1725, 1996.
52. Twumasi DY, Liener IE, Galdston M, Levytska V. Activation of human leukocyte elastase by human a2-macroglobulin. Nature 267: 61-63, 1977.
53. Tyn MT, Gusek TW. Prediction of diffusion coefficients of proteins. Biotechnol Bioeng 35: 327-338, 1990.
54. Virca GD, Travis J. Kinetics of association of human proteinases with human a 2-macroglobulin. J Biol Chem 259: 8870-8874, 1984.
55. Vogelmeier C, Hubbard RC, Fells GA, Schnebli HP, Thompson RC, Fritz H, Crystal RG. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukopro-tease inhibitor. J Clin Invest 87: 482-488, 1991.
56. Wewers MD, Herzyk DJ, Gadek JE. Alveolar fluid neutrophil elastase activity in the adult respiratory distress syndrome is complexed to a-2-macroglobulin. J Clin Invest 82: 1260-1267, 1988.
57. Wiesner O, Litwiller RD, Hummel AM, Viss MA, McDonald CJ, Jenne DE, Fass DN, Specks U. Differences between human proteinase 3 and neutrophil elastase and their murine homologues are relevant for murine model experiments. FEBS Lett 579: 5305-5312, 2005.
58. Willems LN, Otto-Verberne CJ, Kramps JA, ten Have-Opbroek AA, Dijkman JH. Detection of antileukoprotease in connective tissue of the lung. Histochemistry 86: 165-168, 1986.
59. Ying QL, Simon SR. Elastolysis by proteinase 3 and its inhibition by a(1)-proteinase inhibitor: A mechanism for the incomplete inhibition of ongoing elastolysis. Am J Respir Cell Mol Biol 26: 356-361, 2002.
60. Zaher C, Halbert R, Dubois R, George D, Nonikov D. Smoking-related diseases: The importance of COPD. Int J Tuberc Lung Dis 8: 1423-1428, 2004.